Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

CARMINA, Enrico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.382
EU - Europa 3.082
AS - Asia 2.622
SA - Sud America 378
AF - Africa 81
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 9
Totale 12.576
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.311
SG - Singapore 866
RU - Federazione Russa 711
CN - Cina 605
IT - Italia 570
UA - Ucraina 425
HK - Hong Kong 307
BR - Brasile 296
DE - Germania 289
FI - Finlandia 289
VN - Vietnam 258
GB - Regno Unito 170
PL - Polonia 164
IE - Irlanda 162
FR - Francia 134
JP - Giappone 118
BD - Bangladesh 110
KR - Corea 106
SE - Svezia 52
IN - India 45
TR - Turchia 45
CA - Canada 30
NL - Olanda 27
MX - Messico 25
AR - Argentina 23
IQ - Iraq 23
CI - Costa d'Avorio 22
AU - Australia 19
RO - Romania 19
BE - Belgio 17
ZA - Sudafrica 17
PK - Pakistan 16
AT - Austria 14
SA - Arabia Saudita 13
CO - Colombia 12
PH - Filippine 12
VE - Venezuela 12
IR - Iran 11
NP - Nepal 11
UZ - Uzbekistan 10
CL - Cile 9
ES - Italia 9
EU - Europa 8
MA - Marocco 8
BO - Bolivia 7
DZ - Algeria 7
KE - Kenya 7
UY - Uruguay 7
CH - Svizzera 6
EC - Ecuador 6
ID - Indonesia 6
MY - Malesia 6
TN - Tunisia 6
AZ - Azerbaigian 5
JM - Giamaica 5
JO - Giordania 5
AE - Emirati Arabi Uniti 4
PY - Paraguay 4
AL - Albania 3
CR - Costa Rica 3
EG - Egitto 3
IL - Israele 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LB - Libano 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
SN - Senegal 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BG - Bulgaria 2
BH - Bahrain 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GR - Grecia 2
LK - Sri Lanka 2
LT - Lituania 2
MM - Myanmar 2
NG - Nigeria 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
PT - Portogallo 2
RS - Serbia 2
TH - Thailandia 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
CG - Congo 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
GT - Guatemala 1
KH - Cambogia 1
Totale 12.564
Salva come PNG Salva come JPEG
Città #
Fairfield 793
Ashburn 773
Singapore 576
Woodbridge 421
Chandler 364
Houston 363
San Jose 339
Seattle 333
Hong Kong 295
Wilmington 291
Cambridge 259
Jacksonville 226
Ann Arbor 190
Palermo 174
Dublin 160
Zgierz 151
Santa Clara 128
Frankfurt am Main 123
Medford 122
Tokyo 116
Moscow 101
Nanjing 82
Princeton 77
Altamura 75
Ho Chi Minh City 71
Beijing 69
Hanoi 68
Lauterbourg 68
Lawrence 62
Tulsa 62
Los Angeles 61
Boardman 60
Dearborn 59
Council Bluffs 57
San Diego 50
Seongnam 50
New York 43
Hefei 40
Milan 33
Buffalo 32
Dallas 32
Des Moines 32
Shenyang 32
The Dalles 31
Nanchang 29
São Paulo 27
Helsinki 26
Hebei 23
Izmir 23
Abidjan 22
London 22
Columbus 21
Jiaxing 21
Changsha 20
Zhengzhou 18
Chicago 17
Jinan 17
Brussels 16
San Paolo di Civitate 16
Tianjin 15
Amsterdam 14
Guangzhou 14
Haiphong 14
Orem 14
Rio de Janeiro 14
Saint Petersburg 14
Da Nang 13
Ludwigshafen am Rhein 13
Atlanta 12
Auburn Hills 12
Belo Horizonte 12
Brooklyn 12
Verona 11
Montreal 10
Nuremberg 10
Seoul 10
Warsaw 10
Baghdad 9
Cardiff 9
City of London 9
Falls Church 9
Ningbo 9
Redwood City 9
Rome 9
Tashkent 9
Kilburn 8
Kumar 8
Taizhou 8
Denver 7
Dhaka 7
Lanzhou 7
Memphis 7
Montevideo 7
Phoenix 7
Redmond 7
Chennai 6
Curitiba 6
Istanbul 6
Kingston 6
Lahore 6
Totale 8.261
Salva come PNG Salva come JPEG
Nome #
High prevalence of polycystic ovary syndrome in women with mild hirsutism and no other significant clinical symptoms 378
Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. 294
Hypogonadism and hormone replacement therapy on bone mass of Adult Women with Thalassemia Major 241
A 20-year follow-up of young women with Polycystic Ovary Syndrome 222
Does the level of serum antimüllerian hormone predict ovulatory function in women with polycystic ovary syndrome with aging? 221
Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in Southern Italy than in USA and the influence of criteria for the diagnosis of PCOS 217
Low serum levels of 25-hydroxy vitamin D in adults affected by thalassemia major or intermedia. 216
Atherogenic forms of dyslipidemia in women with polycystic ovary syndrome 215
Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis 208
Correlation between deficienty of 25 (oh) vitamin D and liver damage in adult talassemic subjects 204
Prospective parallel randomized double-blind double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first line treatment for ovulation induction in non-obese anovulatory women with polycystic ovary syndrome 203
-Correlation between deficiency of 25 (OH) vitamin D and liver damage in adult talassemic subjects 197
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report 197
PHENOTYPIC VARIATION IN HYPERANDROGENIC WOMEN INFLUENCES THE FINDINGS OF ABNORMAL METABOLIC AND CARDIOVASCULAR RISK PARAMETERS. 195
Consensus on women's health aspects of polycystic ovary syndrome (PCOS) 192
Bone turnover markers in postmenopausal womens treated with alendronate or risedronate: differences in early dynamics 191
Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome. 189
Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome 187
Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group 187
Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome 187
Reproductive outcome of women with 21-hydroxylase deficient non-classic adrenal hyperplasia 187
Androgen excess and cardiovascular risk. 185
The malnutrition in the elderly: a clinical approach. 185
Differences in dyslipidemia between American and Italian women with polycystic ovary syndrome 184
Assessment of cardiovascular risk and prevention of cardiovascular disease in women with Polycystic Ovary Syndrome: a consensus statement of the Androgen Excess and PCOS (AE-PCOS) Society 183
Uterine effects of metformin administration in anovulatory women with polycystic ovary sindrome 182
Body composition of individuals with polycystic ovary syndrome 182
Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes 180
Cardiovascular risk and events in polycystic ovary syndrome 179
Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin and ghrelin 178
OVARIAN AND ADRENAL HYPERANDROGENISM 178
Diagnosis, Phenotype and Prevalence of Polycystic Ovary Syndrome 173
Correlation between deficiency of 25 (OH)-vitamin D, bone mineral density and markers of bone turnover in sicilian postmenopausal womens 170
Influence of sociocultural factors on the ovulatory status of polycystic ovary syndrome. 169
Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society 168
Does metformin induce ovulation in normoandrogenic anovulatory women? 165
Evidence for altered adipocyte function in polycystic ovary syndrome 165
The spectrum of androgen excess disorders 164
Subcutaneous and omental fat expression of adiponectin and leptin in women with polycystic ovary syndrome 164
Emergence of ovulatory cycles with aging in women with polycystic ovary syndrome (PCOS) alters the trajectory of cardiovascular and metabolic risk factors 164
Correlates of increased lean muscle mass in women with polycystic ovary syndrome 164
Lifecycle of Polycystic Ovary Syndrome (PCOS): From In Utero to Menopause 163
The importance of diagnosing the Polycystic Ovary Syndrome 162
Correlation between deficiency of 25 (OH) vitamin D, bone mineral density and markers of bone turnover in sicialian postmenopausal womens 160
Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines 159
Metabolic and cardiopulmonary effects of detraining after a structured exercise training programme in young PCOS women 157
Obesity, Adipokines and Metabolic Syndrome in Polycystic Ovary Syndrome 156
Need for liver evaluation in polycystic ovary syndrome 155
Mullarian-inhibiting substance reflects ovarian findings in women with polycystic ovary syndrome better than does inhibin-B 154
Differences in early dynamics of serum bone markers in women with postmenopausal osteoporosiseated by alendronate or risedronate 150
Introduction to the special issue: 2012 AE-PCOS meeting 149
Ovarian size and blood flow in women with polycystic ovary syndrome (PCOS) and their correlations with some endocrine parameters 148
The diagnosis of polycystic ovary syndrome in adolescents 146
Differences in early dynamics of serum bone markers in women with postmenopausal osteoporosis treated by alendronate or risedronate 142
Not all women diagnosed with PCOS share the same cardiovascular risk profiles 140
Low circulating levels of HDL-cholesterol in women with PCOS and no other lipid abnormalities are associated to increased carotid intima media thickness and finding of atherogenic plaques. 139
Statins and osteoporosis: myth or reality? 136
Birth weight in polycystic ovary syndrome: correlation with adult insulin sensitivity. 134
Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype 131
Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. 129
How should we manage atherogenic dyslipidemia in women with polycystic ovary syndrome? 128
Position statement: criteria for defining Polycystic Ovary Syndrome as predominantly hyperandrogenic syndrome: an androgen excess society guideline 126
Increasing adiposity in normal ovulatory women affects adipocytokine expression in subcutaneous and visceral abdominal fat 126
Fat distribution in idiopathic hyperandrogenism. 122
Editorial 122
Long-term consequences of polycystic ovary syndrome on cardiovascular risk 120
Role of hypogonadism in development of bone alterations in thalassemic patients 118
Endothelial abnormalities in young women with PCOS: correlations with insulin resistance and decreased levels of serum adiponectin 118
Elevated levels of non-HDL-cholesterol are relatively uncommon in women with PCOS and generally reflect LDL-cholesterol levels. 118
Non-classic forms of atherogenic dyslipidemia in women with polycystic ovary syndrome. 118
Metabolic Syndrome in Polycystic Ovary Syndrome 115
When periods stop: cardiovascular consequences of PCOS. 106
Estroprogestins and cardiovascular risk in Polycystic Ovary Syndrome 102
In PCOS women AMH circulating levels predict patients who become ovulatory with aging. 99
Milder forms of atherogenic dyslipidemia in ovulatory vs. anovulatory polycystic ovary syndrome phenotype. 94
PCOS: metabolic impact and long-term management 83
La somministrazione di amfotericina B per via endoarteriosa rappresenta una valida e sicura terapia della mucormicosi 80
Totale 12.715
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.272
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.272
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021107 0 0 0 0 0 0 0 0 0 0 0 107
2021/2022852 29 246 13 22 26 26 61 39 86 82 55 167
2022/2023991 116 224 13 101 126 151 15 81 114 5 38 7
2023/2024388 14 80 27 88 37 70 25 13 1 8 5 20
2024/20251.280 30 139 91 127 50 27 59 94 72 132 148 311
2025/20264.134 254 93 205 200 266 558 552 405 336 956 186 123
Totale 12.715